Eyelash Lenghteners - New Roll Out for Jan Marini
This article is brought to you by Spavelous.com. http://www.spavelous.com
Eyelash lengthener with new formula is about to reach the market
What’s your experience with eyelash lengtheners?
The Jan Marini cosmetic company is about to re-enter the market for eyelash lengtheners that it exited after the Food and Drug Administration seized its supplies of Age Intervention Eyelash in November.
The FDA said that the previous Marini product, which contained bimatoprost, a type of prostaglandin drug, could cause blindness if used in conjunction with a glaucoma drug also containing a prostaglandin.
Marini and other companies selling eyelash lengtheners also faced lawsuits from Irvine-based Allergan, which accuses them of infringing its patents covering use of prostaglandins. Allergan makes Lumigan, a glaucoma medication containing a prostaglandin that some doctors prescribe for eyelash-lengthening, although that is not an FDA-approved use.
Marini says the new $160 Marini Lash contains a “non-prostaglandin” peptide blend that has been tested on about 100 people in the United States and abroad, the Health Blog of the Wall Street Journal reported. As of today, it is not yet on sale.
Dermatologist Dr. Lorrie Klein of Laguna Niguel prescribes Lumigan for patients who want longer eyelashes. Klein says:
It works in 100% of my patients who have tried it. A few have tried the Jan Marini product and RevitaLash also, but they say that Lumigan grows their lashes faster and longer.
Klein says she’s unaware of any other chemical, including any peptide blend, that stimulates eyelash growth.
Allergan is reportedly testing its own version of Lumigan as a potential eyelash-lengthening product.
Related Articles
Spa Secrets For Great Eye Lashes
